Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L
Anneliese S. Ashhurst, Arthur H. Tang, Pavla Fajtová, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2956-2970
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19
Qing Hu, Yuan Xiong, Guanghao Zhu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 144
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
Liyan Yang, Zhonglei Wang
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115503-115503
Open Access | Times Cited: 63
Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer
Liyan Yang, Zhonglei Wang
Biomedicines (2021) Vol. 9, Iss. 6, pp. 689-689
Open Access | Times Cited: 88
SARS-CoV-2 Main Protease Drug Design, Assay Development, and Drug Resistance Studies
Bin Tan, Ryan Joyce, Haozhou Tan, et al.
Accounts of Chemical Research (2022) Vol. 56, Iss. 2, pp. 157-168
Open Access | Times Cited: 61
Bioactive natural products in COVID-19 therapy
Zhonglei Wang, Ning Wang, Liyan Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 56
The Key Role of Lysosomal Protease Cathepsins in Viral Infections
Melania Scarcella, Danila d’Angelo, Mariangela Ciampa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9089-9089
Open Access | Times Cited: 44
Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach
Andreas Wasilewicz, Benjamin Kirchweger, Denisa Bojková, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 2, pp. 264-275
Open Access | Times Cited: 22
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization
Tania Ciaglia, Vincenzo Vestuto, Veronica Di Sarno, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116128-116128
Open Access | Times Cited: 7
Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2
Santanu Mondal, Yongzhi Chen, G.J. Lockbaum, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 46, pp. 21035-21045
Open Access | Times Cited: 35
Marine Natural Products as Leads against SARS-CoV-2 Infection
Bhuwan K. Chhetri, Philip R. Tedbury, Anne Marie Sweeney-Jones, et al.
Journal of Natural Products (2022) Vol. 85, Iss. 3, pp. 657-665
Open Access | Times Cited: 29
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
Kunal Nepali, Ram Lal Sharma, Sachin Sharma, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 28
Lead/Drug Discovery from Natural Resources
Zhihong Xu, Barrett E. Eichler, Eytan A. Klausner, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8280-8280
Open Access | Times Cited: 26
In Silico Analysis Reveals the Inhibitory Potential of Madecassic Acid against Entry Factors of SARS-CoV-2
Abhratanu Ganguly, Moutushi Mandi, Anik Dutta, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 2, pp. 652-662
Closed Access | Times Cited: 14
Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models
Jooeun Lee, Se Yun Jeong, Zijun Li, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 13
Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity
Philipp Flury, Julian Breidenbach, Nadine Krüger, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 2, pp. 493-514
Closed Access | Times Cited: 4
Informatics and Computational Approaches for the Discovery and Optimization of Natural Product-Inspired Inhibitors of the SARS-CoV-2 2′-O-Methyltransferase
George S. Hanna, Menny M. Benjamin, Yeun‐Mun Choo, et al.
Journal of Natural Products (2024) Vol. 87, Iss. 2, pp. 217-227
Open Access | Times Cited: 4
Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies
Queency N. Okechukwu, Feyisayo O. Adepoju, Osman N. Kanwugu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 328-328
Open Access | Times Cited: 4
Nature-Inspired Gallinamides Are Potent Antischistosomal Agents: Inhibition of the Cathepsin B1 Protease Target and Binding Mode Analysis
Petra Spiwoková, Martin Horn, Jindřich Fanfrlík, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 6, pp. 1935-1948
Open Access | Times Cited: 4
Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice
Anneliese S. Ashhurst, Matt D. Johansen, Joshua W. C. Maxwell, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 21
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors
Santo Previti, Roberta Ettari, Elsa Calcaterra, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115021-115021
Open Access | Times Cited: 19
Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV)
Chamandi S. Dampalla, Matthew J. Miller, Yunjeong Kim, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115376-115376
Open Access | Times Cited: 10
Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411
Robert Konkel, Aleksandra Milewska, Thuc Nguyen Dan, et al.
Antiviral Research (2023) Vol. 219, pp. 105731-105731
Open Access | Times Cited: 10
SARS-CoV-2 Infects Hamster Testes
Rafael K. Campos, Vidyleison Neves Camargos, Sasha R. Azar, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1318-1318
Open Access | Times Cited: 24
Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 6, pp. 100079-100079
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top